Mohammad Issam Abu Zaid

Statistics

Publications

Citations

176

H-Index

Active since

2017

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University Health

Fred Hutch Cancer Center

Memorial Sloan Kettering Cancer Center

University of Minnesota

Mohammad Issam Abu Zaid is an author at Indiana University – Purdue University Indianapolis specializing in immunotherapy, oncology, and graft-versus-host disease pathophysiology.

Publications per year

2017–2022

Publications

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study

Sarah L. Kerns, Chunkit Fung, Patrick O. Monahan et al. · Journal of Clinical Oncology · 2018 · 127 citations · Full text

Medicine, Biostatistics, Oncology +17

A phase II study of buparlisib in relapsed or refractory thymomas

Mohammad Issam Abu Zaid, Milan Radovich, Sandra K. Althouse et al. · Frontiers in Oncology · 2022 · 15 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

Mukta Arora, Madan Jagasia, Antonio Di Stasi et al. · Blood · 2020 · 13 citations

Life Sciences, Immunology, Oncology +13

Safety, Tolerability, and Efficacy of Axatilimab, a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

Stephanie J. Lee, Mukta Arora, Zachariah DeFilipp et al. · Blood · 2021 · 11 citations

Life Sciences, Clinical Sciences, Immunology +14

Adverse health outcomes in relationship to hypogonadism (HG) after platinum-based chemotherapy: A multicenter study of North American testicular cancer survivors (TCS).

Mohammad Issam Abu Zaid, Alvaro G. Menendez, Omar El Charif et al. · Journal of Clinical Oncology · 2017 · 10 citations

Medicine, Endocrinology, Genetics +17

1–5 of 5